CD8A and nonpapillary renal cell carcinoma: Notably, compared to the majority of other types of immunotherapy-responsive solid tumors, ccRCC has a modest mutational burden; therefore, an increasing number of studies focus on the predictive value of TICs, such as CD8 T cell proportion (Lawrence et al., 2013).